尽管丘奇＆德怀特（Church & Dwight）的股票在过去一年表现不及同业，但雷蒙德·詹姆斯（Raymond James）的分析师认为，这一局面不会持续太久。在一份研究报告中，分析师指出，考虑到这家消费品公司拥有防御性产品组合，且估值相较于竞争对手处于低位，他们预计其股价将在2026年实现超越。
这家旗下拥有Arm & Hammer和OxiClean等品牌的生产商近期销售额和盈利表现稳健，其偏重价值的产品组合使其能够从容应对各种宏观经济变化。分析师补充道，近年来，丘奇＆德怀特在并购方面一直保持自律，并且公司有望从剥离其维生素业务中获益。
基于以上因素，雷蒙德·詹姆斯将丘奇＆德怀特的评级从“与大市同步”上调至“跑赢大市”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.